A new study shows that mobile medical applications can benefit diabetics | Instant News

A kind Recent studies It has been found that mobile health apps can benefit diabetics, and diabetes Patients can improve their health and reduce medication costs.

The research results will be published in the “MIS Quarterly” magazine of “Management Information System Research Center”.

The emerging smart mobile medical or mHealth technology is changing the way patients track information related to the diagnosis. This study examines the health and economic impact of mobile health technology on the outcomes of Asian diabetic patients.

The study concluded that patients who use these apps have better health conditions and are able to regulate their health behaviors more effectively than those who do not use mHealth apps. They also reduced the number of medical visits and reduced medical expenses. The research was conducted by researchers from Carnegie Mellon University (CMU) and New York University (NYU).

Li Beibei explained: “In view of the importance of healthy behaviors to well-being, health outcomes and disease processes, mobile health technology offers great potential for promoting patient lifestyle and behavior changes through patient education, improved self-regulation and perception. “CMU’s Heinz College Information Systems and Management Professor is the co-author of the study.

The relatively new areas of mobile medicine include mobile computing, medical sensors, and communication technologies for medical services (eg, managing chronic diseases). Mobile health applications can run on smartphones, tablets, sensors and cloud-based computing systems, all of which can collect personal health data.

It is estimated that by the end of 2020, the global mobile medical market will reach 49 billion US dollars. However, few studies have evaluated the effectiveness of this technology in changing patient behavior and outcomes.

In this study, researchers tried to determine how the mHealth app can persuade individuals to modify their behavior to follow suggested methods to achieve certain health goals. , Food intake) as well as the overall health of the application, visits and medical expenses.

The researchers collaborated with a top mHealth company, which provides one of Asia’s largest mobile medical platforms dedicated to diabetes care. The study randomly assigned 1,070 adult patients to different groups within three months: some patients used the mHealth app, some did not use it, and some used a web-based app. In the group using the mHealth app, some patients received personalized SMS reminders, while others received non-personalized text messages.

The researchers interviewed all participants before the start of the study and five months after the end of the study. Questions raised included demographics, medication and medical history, blood sugar and hemoglobin levels, frequency of visits, and medical expenses.

The study found that even after controlling for personal level fixation, patients using the mHealth app also reduced blood sugar and hemoglobin levels. Patients using the app also exercised more, slept more and ate healthier foods. And they go to the hospital less often and the medical expenses are lower.

The author believes that the adoption and use of the mHealth app by patients will lead to significant behavior changes, which will lead to a healthier diet and lifestyle. In this way, users can self-regulate their health behaviors more autonomously, and this growing inner motivation helps them become more involved, lasting and stable, thereby improving their health.

The mHealth platform also promotes more use of telemedicine, thereby reducing the number of patient visits and medical expenses. The study also found that the mHealth platform is more effective than the Web-based PC version in improving the health of patients.

Non-personalized text messages are often more effective in changing patient behavior than personalized messages. This may be because personalized messages can be considered intrusive, mandatory, and annoying.

Among the limitations of the study, the authors pointed out that the study is mainly for participants with type II diabetes, which is different from type I diabetes or gestational diabetes, which is directly related to self-management of diet or lifestyle. Therefore, this study is not necessarily applicable to other types of diabetes patients.

Anindya Ghose, professor of business at New York University’s Stern School of Business, said: “Our findings provide important information for the design of mHealth apps by better understanding patients’ health behaviors and interactions with platforms. Insight.”

Ghose added: “Such knowledge may be very valuable to healthcare mobile platform designers and decision makers, who continue to use emerging technologies to improve the design of smart and connected healthcare infrastructure.”


image source

to request modification Contact us at Here or [email protected]